col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


129 Ergebisse       Seite 1

 [1] 
Oxford University Press: Inflammatory Bowel Diseases
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Jun―24 The Dual Role of ACE2 in IBD: Balancing SARS-CoV-2 Susceptibility and Gut Homeostasis Laura Francesca Pisani, Guglielmo Albertini Petroni, Luca Pastorelli, Chiara Porta
2 [GO] 2025―Mai―11 Past But Not Forgotten: Innate Factors Affect the Course of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Inflammatory Bowel Disease Georgios Kokkotis, Giorgos Bamias
3 [GO] 2025―Apr―25 Lower Expression of SARS-CoV-2 Host Cell Entry Genes in the Intestinal Mucosa of IBD Patients With Quiescent or Mildly Active Disease Laura Francesca Pisani, Gugliemo Albertini Petroni, Giorgia Crespi, Silvia Mola, Maria Laura Annunziata, Flavio Andrea Caprioli, et al. (+2)
4 [GO] 2024―Okt―16 Durable Immune Response and Long-term Efficacy of COVID-19 Vaccination in Children With Inflammatory Bowel Disease Arthur J Kastl, Erica J Brenner, Kimberly N Weaver, Xian Zhang, Jennifer A Strople, Jeremy Adler, et al. (+19)
5 [GO] 2024―Jan―25 THE BURDEN OF INFLAMMATORY BOWEL DISEASE ON COVID-19 HOSPITALIZATIONS: A NATIONWIDE ANALYSIS Humzah Iqbal, Rakahn Haddadin, Hasib Haidary, Patrick Zhang, Devang Prajapati
6 [GO] 2024―Jan―25 EXPLORING FACTORS ASSOCIATED WITH SEROLOGICAL RESPONSE TO SARS-COV-2 VACCINES IN INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE: INTERACTIVE VISUALIZATION METHODS FOR MULTIDIMENSIONAL DATA Lindsay Hracs, Joshua Quan, Christopher Ma, Remo Panaccione, Nastaran Sharifi, Michelle Herauf, et al. (+13)
7 [GO] 2023―Nov―08 Antibody, not Cellular, Immune Responses to SARS-CoV-2 Vaccination Outperform Infection in Inflammatory Bowel Disease Patients Elizabeth González Cueto, Matthew Edmans, Judith Wellens, Ken Cadwell, Craig Thompson, Jack Satsangi, et al. (+9)
8 [GO] 2023―Okt―10 SARS-CoV-2 Serological Response in Patients With Inflammatory Bowel Disease Amnuay Kleebayoon, Viroj Wiwanitkit
9 [GO] 2023―Sep―29 Postvaccination Symptoms After a Fourth Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease Yoo Jin Lee, Dalin Li, Angela Mujukian, Philip Debbas, Melissa Hampton, Emebet Mengesha, et al. (+72)
10 [GO] 2023―Sep―19 Predictors of Hospital-related Outcomes of COVID-19 Infection in Patients With Inflammatory Bowel Disease in the Early Pandemic Phase: A Nationwide Inpatient Database Survey Khadija Naseem, Abdullah Sohail, Vu Quang Nguyen, Ahmad Khan, Gregory Cooper, Bret Lashner, et al. (+4)
11 [GO] 2023―Aug―05 Corticosteroids but not Anti-TNF Are Associated With Increased COVID-19 Complications in Patients With Inflammatory Bowel Disease Millie D Long, Lauren Parlett, James D Lewis, Kevin Haynes, Sruthi Adimadhyam, Laura Hou, et al. (+5)
12 [GO] 2023―Aug―04 Increased Risk of Herpes Zoster in Adult Patients with Inflammatory Bowel Disease After SARS-CoV2 Infection: A Propensity-Matched Cohort Study Aakash Desai, Aakriti Soni, Mary S Hayney, Jana G Hashash, Gursimran S Kochhar, Francis A Farraye, Freddy Caldera
13 [GO] 2023―Jun―30 Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study Fabio Salvatore Macaluso, Mariabeatrice Principi, Federica Facciotti, Antonella Contaldo, Alessia Todeschini, Simone Saibeni, et al. (+41)
14 [GO] 2023―Jun―25 Geography Influences Susceptibility to SARS-CoV-2 Serological Response in Patients With Inflammatory Bowel Disease: Multinational Analysis From the ICARUS-IBD Consortium Serre-Yu Wong, Judith Wellens, Drew Helmus, Luke Marlow, Stephanie Brann, Vicky Martinez Pazos, et al. (+80)
15 [GO] 2023―Jun―07 Postvaccination Symptoms After SARS-CoV-2 mRNA Vaccination Among Patients With Inflammatory Bowel Disease: A Prospective, Comparative Study Angela Mujukian, Rashmi Kumar, Dalin Li, Philip Debbas, Gregory J Botwin, Susan Cheng, et al. (+53)
16 [GO] 2023―Apr―18 Additional COVID-19 Booster Doses Increase Anti-spike Serum Antibody Concentrations Among Patients With Inflammatory Bowel Disease Trevor L Schell, Oscar Ramirez, Mazen Almasry, Francis A Farraye, Mary S Hayney, Freddy Caldera
17 [GO] 2023―Apr―17 COVID-19 Does Not Lead to an Increase in Corticosteroid Prescriptions in IBD Patients: A Nationwide Cohort Study Bente Mertz Nørgård, Floor Dijkstra Zegers, Jan Nielsen, Torben Knudsen, Jens Kjeldsen
18 [GO] 2023―Mrz―31 Long-Term Impact of the COVID-19 Pandemic on Inflammatory Bowel Disease Healthcare Utilization: A 2-Year Nationwide Update Monica E W Derks, Lisa M A van Lierop, Maarten te Groen, Chantal C H J Kuijpers, Iris D Nagtegaal, Frank Hoentjen
19 [GO] 2023―Mrz―21 Assessing the Impact of COVID-19 on IBD Outcomes Among Vulnerable Patient Populations in a Large Metropolitan Center Florence-Damilola Odufalu, Justin L Sewell, Vivek Rudrapatna, Ma Somsouk, Uma Mahadevan
20 [GO] 2023―Feb―15 Persistence of Antibodies Six Months after Three COVID-19 mRNA Vaccine Doses in Patients with Inflammatory Bowel Disease Freddy Caldera, Luke Richard, Mazen Almasry, Hiep Phan, Kelly Chun, Francis A Farraye, Mary S Hayney
21 [GO] 2023―Jan―30 Reply to “Patients With Inflammatory Bowel Disease on Anti-TNF Therapy and COVID-19 Vaccination” Hiep Phan, Mary S Hayney, Freddy Caldera
22 [GO] 2022―Dez―29 Patients With Inflammatory Bowel Disease on Anti-TNF Therapy and COVID-19 Vaccination: Correspondence Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
23 [GO] 2022―Dez―28 Effect of 2 vs 3 Doses of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease: A Population-based Propensity Matched Analysis Aakash Desai, Parakkal Deepak, Raymond K Cross, Julie Murone, Francis A Farraye, Ryan C Ungaro, Gursimran S Kochhar
24 [GO] 2022―Nov―02 Impact of Biologic Agents on the Immune Response Induced by the Additional Dose of SARS-CoV-2 Vaccine in Inflammatory Bowel Disease Patients Laura Ramos, Miriam Hernández-Porto, Marta Carrillo-Palau, Inmaculada Alonso-Abreu, Cristina Reygosa, Manuel Hernandez-Guerra
25 [GO] 2022―Sep―14 Higher Cell-Mediated Immune Responses in Patients With Inflammatory Bowel Disease on Anti-TNF Therapy After COVID-19 Vaccination Freddy Caldera, Francis A Farraye, Brian M Necela, Davitte Cogen, Sumona Saha, Arnold Wald, et al. (+13)
26 [GO] 2022―Sep―13 Humoral Immunogenicity After Vaccination Against SARS-CoV-2 Infection in Inflammatory Bowel Disease Patients Under Immunosuppressive Therapy: Should We Prioritize an Additional Booster Injection? Vítor Macedo Silva, Tiago Lima Capela, Marta Freitas, Tiago Cúrdia Gonçalves, Pedro Boal Carvalho, Francisca Dias de Castro, et al. (+2)
27 [GO] 2022―Aug―23 Postvaccination Symptoms After a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease: Results From CORALE-IBD Dalin Li, Philip Debbas, Angela Mujukian, Susan Cheng, Jonathan Braun, Dermot P B McGovern, et al. (+66)
28 [GO] 2022―Aug―16 IBD Flare in the COVID-19 Pandemic: Therapy Discontinuation Is to Blame Cristina Bezzio, Gionata Fiorino, Davide G Ribaldone, Alessandro Armuzzi, Simone Saibeni, Marta Vernero, et al. (+35)
29 [GO] 2022―Jul―13 Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease Kimberly N Weaver, Xian Zhang, Xiangfeng Dai, Wenli Chen, Runa Watkins, Jeremy Adler, et al. (+17)
30 [GO] 2022―Jun―28 De Novo Pediatric Ulcerative Colitis Triggered by SARS-CoV-2 Infection: a Tale of 2 Sisters Nicholas A Preziosi, Areeba H Rizvi, John D Feerick, Chetan Mandelia
31 [GO] 2022―Jun―06 Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: A Survey From China Wen-ning Tian, Yu-hong Huang, Cong Dai
32 [GO] 2022―Mai―31 Correspondence on “Immunogenicity of COVID-19 Vaccine Doses in Patients With Inflammatory Bowel Disease” Pathum Sookaromdee, Viroj Wiwanitkit
33 [GO] 2022―Apr―09 Humoral Immunogenicity of 3 COVID-19 Messenger RNA Vaccine Doses in Patients With Inflammatory Bowel Disease Trevor L Schell, Keith L Knutson, Sumona Saha, Arnold Wald, Hiep S Phan, Mazen Almasry, et al. (+6)
34 [GO] 2022―Apr―09 Prevalence of SARS-COV-2 Vaccination and Factors Impacting Likelihood of Vaccination in a Nationwide Veterans Affairs Cohort of IBD Patients Nadim Mahmud, Yash Shah, Nabeel Khan
35 [GO] 2022―Apr―09 The T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF Therapy Dalin Li, Alexander Xu, Emebet Mengesha, Rebecca Elyanow, Rachel M Gittelman, Heidi Chapman, et al. (+18)
36 [GO] 2022―Apr―08 Reply to Response to “‘A Case of Ulcerative Colitis Relapse Characterized by Systemic Type I Interferon Responses After COVID-19 Vaccination’” by Mungmunpuntipantip and Wiwanitkiton Yasuhiro Masuta, Tomohiro Watanabe, Kosuke Minaga, Masatoshi Kudo
37 [GO] 2022―Apr―08 Ulcerative Colitis Relapse After COVID-19 Vaccination: Correspondence Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
38 [GO] 2022―Apr―06 Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19 Fabio Salvatore Macaluso, Alessandra Giuliano, Walter Fries,, Anna Viola, Alfredo Abbruzzese, et al. (+20)
39 [GO] 2022―Apr―01 Response to: COVID-19 Vaccination, Willingness, Hesitancy, and Inflammatory Bowel Diseases Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
40 [GO] 2022―Mrz―25 Association Between the Clinical, Biochemical, and Endoscopic Activity of Inflammatory Bowel Diseases and Severity and Long-term Outcomes of Coronavirus Disease 2019-A Population-based Study Mohamed Attauabi, Jens Frederik Dahlerup, Anja Poulsen, Malte Rosager Hansen, Marianne Kajbæk Vester-Andersen, August Pilegaard Prahm, et al. (+14)
41 [GO] 2022―Mrz―03 Outcomes of COVID-19 Infections in Vaccinated Patients with Inflammatory Bowel Disease: Data From an International Registry Emily Spiera, Danielle Y Ganjian, Xian Zhang, Erica J Brenner, Manasi Agrawal, Jean-Frederic Colombel, et al. (+3)
42 [GO] 2022―Feb―26 A Case of Ulcerative Colitis Relapse Characterized by Systemic Type I Interferon Responses after COVID-19 Vaccination Yasuhiro Masuta, Tomohiro Watanabe, Kosuke Minaga, Masatoshi Kudo
43 [GO] 2022―Feb―22 SARS-CoV-2 Infection in the Follow-Up of a Population With Inflammatory Bowel Disease Rodrigo Quera, Paulina Núñez F, Lilian Flores
44 [GO] 2022―Jan―22 COVID-19 INFECTIONS IN VACCINATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OUTCOMES AND RISK FACTORS FOR SEVERE DISEASE Emily Spiera, Danielle Ganjian, Xian Zhang, Erica Brenner, Manasi Agrawal, Jean-Frederic Colombel, et al. (+3)
45 [GO] 2022―Jan―22 EFFECTS OF DELAYED ENDOSCOPIES IN INFLAMMATORY BOWEL DISEASE PATIENTS DURING THE COVID-19 PANDEMIC Karen Young, Devesh Hargunani, Vitaliy Poylin
46 [GO] 2022―Jan―22 ACUITY OF PEDIATRIC INFLAMMATORY BOWEL DISEASE ADMISSIONS PRE AND DURING THE COVID-19 PANDEMIC Malika Waschmann, Ariana Stuart, Henry Lin, Anna Hunter
47 [GO] 2022―Jan―22 FEAR OF THE COVID-19 PANDEMIC IN ADOLESCENTS AND YOUNG ADULTS WITH INFLAMMATORY BOWEL DISEASE: RELATIONSHIP TO PSYCHOLOGICAL AND PHYSICAL OUTCOMES Nicole Neiman, Kavya Anjur, Ann Ming Yeh, Rachel Bensen, Anava Wren
48 [GO] 2022―Jan―22 EVALUATING THE IMPACT OF THE COVID-19 PANDEMIC ON URGENT MEDICAL ACCESS FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE AT A PRIVATE COMMUNITY GASTROENTEROLOGY PRACTICE Michelle Kwon, Chung Sang Tse, Welmoed van Deen, Michael Danielewicz, Christopher Ward, Lawrence Kogan, et al. (+2)
49 [GO] 2022―Jan―22 SAFETY AND EFFECTIVENESS OF THE BNT162B2 MRNA COVID-19 VACCINE IN A NATIONWIDE COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE Muhammad Khan, Kamran Mushtaq, Muhammad Saddique, Mohd Alghizzawi, Muhammad Yasir, Hafiz Younis, et al. (+5)
50 [GO] 2022―Jan―22 SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY Joshua Quan, Christopher Ma, Remo Panaccione, Jamil Kanji, Graham Tipples, Nastaran Sharifi, et al. (+18)
51 [GO] 2022―Jan―15 The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend Analysis Gilaad G Kaplan, Fox E Underwood, Stephanie Coward, Manasi Agrawal, Ryan C Ungaro, Erica J Brenner, et al. (+11)
52 [GO] 2021―Dez―18 Inflammatory Bowel Disease Triggered by BNT162b2 mRNA Vaccination for SARS-CoV-2 Yosuke Shimodaira, Kenta Watanabe, So Takahashi, Shigeto Koizumi, Katsunori Iijima
53 [GO] 2021―Dez―06 Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID Kimberly N Weaver, Xian Zhang, Xiangfeng Dai, Runa Watkins, Jeremy Adler, Marla C Dubinsky, et al. (+13)
54 [GO] 2021―Dez―01 COVID-19 as a Trigger for De Novo Crohn’s Disease Antonio Tursi, Rosanna Nenna
55 [GO] 2021―Dez―01 Mesalazine in Inflammatory Bowel Disease and COVID-19: Hospitalization and Adverse In-Hospital Outcomes Based on Nationwide Data Simon Kjeldsen, Jan Nielsen, Bente Mertz Nørgård, Jens Kjeldsen
56 [GO] 2021―Dez―01 Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice David M Alvarado, Juhee Son, Larissa B Thackray, Maria Florencia Gomez Castro, Sarada Prasad, Xueyang Cui, et al. (+4)
57 [GO] 2021―Nov―18 Letter of Reply to “Response to: COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients’ Association” Andrea Costantino, Daniele Noviello, Claudio Costantino, Maurizio Vecchi, Flavio Caprioli
58 [GO] 2021―Okt―31 COVID-19 and Outcomes in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-Analysis Kartikeya Tripathi, Gala Godoy Brewer, Minh Thu Nguyen, Yuvaraj Singh, Mohamed Saleh Ismail, Jenny S Sauk, et al. (+2)
59 [GO] 2021―Sep―24 Addressing COVID-19 Vaccine Hesitancy in Patients with IBD Dania Hudhud, Freddy Caldera, Raymond K Cross
60 [GO] 2021―Sep―16 Antibody Responses to SARS-CoV-2 After Infection or Vaccination in Children and Young Adults With Inflammatory Bowel Disease Joelynn Dailey, Lina Kozhaya, Mikail Dogan, Dena Hopkins, Blaine Lapin, Katherine Herbst, et al. (+8)
61 [GO] 2021―Aug―24 Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients Elizabeth A Spencer, Eyal Klang, Michael Dolinger, Nanci Pittman, Marla C Dubinsky
62 [GO] 2021―Aug―23 Potential Value of Electroacupuncture in the Treatment of Gastrointestinal Symptoms of COVID-19 Xianqiang Yu
63 [GO] 2021―Jul―28 New Gastrointestinal Symptoms Are Common in Inflammatory Bowel Disease Patients With COVID-19: Data From an International Registry Ryan C Ungaro, Manasi Agrawal, Erica J Brenner, Xian Zhang, Jean-Frederic Colombel, Michael D Kappelman, Walter Reinisch
64 [GO] 2021―Jul―14 COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients’ Association Andrea Costantino, Daniele Noviello, Francesco Simone Conforti, Marina Aloi, Alessandro Armuzzi, Fabrizio Bossa, et al. (+12)
65 [GO] 2021―Jun―28 SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease-Fear and Desire Jens Walldorf, Ulrike von Arnim, Renate Schmelz, Anica Riesner-Wehner, Patrick Michl, Philip C Grunert, et al. (+3)
66 [GO] 2021―Jun―05 Acceptance of SARS-CoV-2 Vaccination Among a Cohort of IBD Patients From Southern Italy: A Cross-Sectional Survey Federica Crispino, Daniele Brinch, Lucio Carrozza, Maria Cappello
67 [GO] 2021―Mai―20 Ensuring High and Equitable COVID-19 Vaccine Uptake Among Patients With IBD Freddy Caldera, Sophie Balzora, Mary S Hayney, Francis A Farraye, Raymond K Cross
68 [GO] 2021―Mai―17 COVID-19 Vaccination in Patients With Inflammatory Bowel Disease and History of Reaction to Injectable Therapies Jacqueline D Squire, Alexei Gonzalez-Estrada, Freddy Caldera, Francis A Farraye
69 [GO] 2021―Mai―14 Impact of COVID-19 on Inflammatory Bowel Disease Clinical Trial Recruitment: A Global Survey of Principal Investigators Vipul Jairath, Leonardo Guizzetti, K Adam Baker, Lee Anne Williamson, Rocio Sedano, Hershell Thompson, Christopher Ma
70 [GO] 2021―Apr―27 COVID-19 Hospitalizations Among U.S. Medicare Beneficiaries With Inflammatory Bowel Disease, April 1 to July 31, 2020 Fang Xu, Susan A Carlson, Anne G Wheaton, Kurt J Greenlund
71 [GO] 2021―Mrz―30 Safety of Tofacitinib in the COVID-19 Pandemic-Enough Is Not Enough Philipp A Reuken, Niels Teich, Andreas Stallmach
72 [GO] 2021―Mrz―11 The Effect of COVID-19 Resurgence on Morbidity and Mortality in Patients With IBD on Biologic Therapy Srdjan Markovic, Tamara Knezevic Ivanovski, Branimir Zogovic, Ana Kalaba, Dusan Zaric, Petar Svorcan
73 [GO] 2021―Feb―22 Leukocytoclastic Vasculitis in Cutaneous Crohn Disease in the Setting of COVID-19 Najib Nassani, Nadera Sweiss, John Thomas Berry, Clarence Calhoun, Anne Polick, Itishree Trivedi
74 [GO] 2021―Feb―22 SARS-CoV-2 as a Trigger for De Novo Ulcerative Colitis Nicola Imperatore, Raffaele Bennato, Alfredo D’Avino, Giovanni Lombardi, Francesco Manguso
75 [GO] 2021―Feb―12 Time to Negative SARS-CoV-2 PCR Should Not Delay Care Among Patients With Inflammatory Bowel Diseases Rachel W Winter, Ashwin Ananthakrishnan, Kristin E Burke, Bharati Kochar, Walter W Chan, Jessica R Allegretti
76 [GO] 2021―Jan―29 Commenting on the Letter (Completing the Picture in Egypt: Response to “Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic”) Mohamed Eltabbakh, Waleed Abd Alaty, Mohamed Amin Sakr, Ahmed F Sherief
77 [GO] 2021―Jan―29 Completing the Picture in Egypt: Response to “Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic” Mohammed Khorshid, Mohamed AbdAllah
78 [GO] 2021―Jan―21 PATIENTS WITH INFLAMMATORY BOWEL DISEASE PERSPECTIVE ON COVID-19 AND HEALTH CARE SERVICE DURING THE PANDEMIC Randi Opheim, Kristian Moum, Bjørn Moum
79 [GO] 2021―Jan―21 A POPULATION-BASED APPROACH TO DIGITAL OUTREACH, TRIAGE, AND MONITORING OF IBD PATIENTS DURING THE COVID-19 PANDEMIC Ashish Atreja, Farah Fasihuddin, Shashank Garge, Liana Davidoff, Jonathan Rubin, Sarthak Kakkar, et al. (+6)
80 [GO] 2021―Jan―21 TELEMEDICINE IN IBD: GOOD TRUST FROM OUTPATIENTS DURING THE COVID-19 PANDEMIC IN MILAN (LOMBARDY) Andrea Costantino, Daniele Noviello, Stefano Mazza, Roberto Berté, Maurizio Vecchi, Flavio Caprioli
81 [GO] 2021―Jan―21 RISK OF ADVERSE OUTCOMES IN HOSPITALIZED PATIENTS WITH AUTOIMMUNE DISEASE AND COVID-19: A MATCHED COHORT STUDY FROM NEW YORK CITY Adam Faye, Kate Lee, Monika Laszkowska, Judith Kim, John Blackett, Anna McKenney, et al. (+8)
82 [GO] 2021―Jan―21 SARS-COV-2 INFECTION AND SEROCONVERSION IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS Wenly Ruan, Faith Ihekweazu, Seema Walsh, Lina Karam, Allyson Wyatt, Huyen Nguyen, Richard Kellermayer
83 [GO] 2021―Jan―21 INCREASED CATHEPSIN EXPRESSION CORRELATES WITH SARS-COV-2 INFECTION IN HUMAN IBD ENTEROIDS David Alvarado, Maria Gomez Castro, Naomi Sonnek, Xueyang Cui, Siyuan Ding, Matthew Ciorba
84 [GO] 2020―Dez―16 Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry Manasi Agrawal, Erica J Brenner, Xian Zhang, Irene Modesto, John Woolcott, Ryan C Ungaro, et al. (+2)
85 [GO] 2020―Nov―30 Ileum Perforation in Crohn’s Disease Patient During SARS-Cov-2 Infection Genoile Oliveira Santana, Andréa Canário de Santana, Vanessa Barto Pfeilsticker
86 [GO] 2020―Okt―22 Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases Kristin E Burke, Bharati Kochar, Jessica R Allegretti, Rachel W Winter, Paul Lochhead, Hamed Khalili, et al. (+4)
87 [GO] 2020―Okt―16 Unraveling the Role of ACE2, the Binding Receptor for SARS-CoV-2, in Inflammatory Bowel Disease Mariana Ferreira-Duarte, Maria Manuela Estevinho, Margarida Duarte-Araújo, Fernando Magro, Manuela Morato
88 [GO] 2020―Okt―12 COVID-19 Pandemic’s Effects on Disease and Psychological Outcomes of People With Inflammatory Bowel Disease in Portugal: A Preliminary Research Inês A Trindade, Nuno B Ferreira
89 [GO] 2020―Okt―12 Biological Therapy for Inflammatory Bowel Disease During the COVID-19 Pandemic: Experiences From a Tertiary IBD Service Srdjan Markovic, Tamara Knezevic Ivanovski, Branimir Zogovic, Mirjana Cvetkovic, Petar Svorcan
90 [GO] 2020―Okt―12 SARS-CoV-2 Infection and Dual-Biologic Therapy for Crohn’s Disease Christina Dimopoulos, Badr Al-Bawardy
91 [GO] 2020―Okt―08 Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey Massimo Caludio Fantini, Livia Biancone, Gabriele Dragoni, Cristina Bezzio, Agnese Miranda, Davide Giuseppe Ribaldone, et al. (+40)
92 [GO] 2020―Sep―19 COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy Chiara Viganò, Sara Massironi, Lorena Pirola, Laura Cristoferi, Maria Fichera, Marianna Bravo, et al. (+4)
93 [GO] 2020―Sep―09 Establishing Safe Out-of-Hospital Infusion Centers May Improve the Quality of Care in Patients With IBD During the COVID-19 Pandemic Catherine Behzad, Hassan Taheri, Mehrdad Kashifard
94 [GO] 2020―Sep―03 Management of Inflammatory Bowel Disease and COVID-19 in New York City 2020: The Epicenter of IBD in the First Epicenter of the Global Pandemic Asher Kornbluth, Michele Kissous-Hunt, James George, Peter Legnani
95 [GO] 2020―Sep―01 Biologic Therapies May Reduce the Risk of COVID-19 in Patients With Inflammatory Bowel Disease Cristina Bezzio, Lucienne Pellegrini, Gianpiero Manes, Ilaria Arena, Desirée Picascia, Cristina Della Corte, et al. (+3)
96 [GO] 2020―Aug―31 Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic Mohamed Mahmoud Eltabbakh, Mostafa Abd Alfatah Shamkh, Ahmed Nagah Bassuny, Waleed Hamed Abd Alaty, Mohamed Amin Sakr, Ahmed Fouad Sherief
97 [GO] 2020―Aug―24 Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: A Single-Center Study in Madrid, Spain Ivan Guerra, Alicia Algaba, Laura Jiménez, Mª Mar Aller, Daniel Garza, Daniel Bonillo, et al. (+2)
98 [GO] 2020―Aug―19 Management of Immune-Related Colitis During the COVID-19 Pandemic Rajan Amin, Anusha S Thomas, Shruti Khurana, Kavea Panneerselvam, Fangwen Zou, Weijie Ma, et al. (+2)
99 [GO] 2020―Aug―19 Innovation in IBD Care During the COVID-19 Pandemic: Results of a Cross-Sectional Survey on Patient-Reported Experience Measures Carlos Taxonera, Cristina Alba, David Olivares, María Martin, Alejandro Ventero, Mercedes Cañas
100 [GO] 2020―Aug―19 Ambulatory Management of Acute Severe Ulcerative Colitis: A Pandemic-driven Initiative Tristan Townsend, Joseph Fiske, Paul Collins, Ashley Bond, Alan Steel, Martyn Dibb, et al. (+2)
101 [GO] 2020―Aug―14 Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey Charles N Bernstein, Siew C Ng, Rupa Banerjee, Flavio Steinwurz, Bo Shen, Franck Carbonnel, et al. (+48)
102 [GO] 2020―Aug―01 Inflammatory Bowel Disease Management in a Major Referral Center During COVID-19 Pandemic Isabel Garrido, Susana Lopes, Guilherme Macedo
103 [GO] 2020―Aug―01 Management of IBD Patients Who Are Unwilling or Unable to Receive Infusion Therapy During the COVID-19 Pandemic Jamie M Horrigan, Corey A Siegel, Micheal Tadros
104 [GO] 2020―Jul―31 The Effect of the COVID-19 Pandemic on the Medical Mode of Patients With Inflammatory Bowel Disease in China Wen-ning Tian, Yu-hong Huang, Cong Dai
105 [GO] 2020―Jul―28 Italian IBD Patients Coping With Covid-19 Emergency: The Mitigating Role of Psychological Readiness to Engage in Self-care Greta Castellini, Mariarosaria Savarese, Salvatore Leone, Enrica Previtali, Alessandro Armuzzi, Guendalina Graffigna
106 [GO] 2020―Jul―28 Response to “Italian IBD Patients Coping With COVID-19 Emergency: The Mitigating Role of Psychological Readiness to Engage in Self-Care” Vincenzo Occhipinti, Orsola Raffaella Sociale, Luca Pastorelli
107 [GO] 2020―Jul―28 Fogging IBD Management: An Unusual Case of IBD Flare-up During the COVID-19 Outbreak Alessandro Rimondi, Gian Eugenio Tontini, Stefano Mazza, Flavio Caprioli, Angelo Sangiovanni, Pietro Lampertico, Maurizio Vecchi
108 [GO] 2020―Jul―28 The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications Franco Scaldaferri, Gianluca Ianiro, Giuseppe Privitera, Loris Riccardo Lopetuso, Lorenzo Maria Vetrone, Valentina Petito, et al. (+8)
109 [GO] 2020―Jul―17 Safety of Endoscopy in Patients With Inflammatory Bowel Disease During the COVID-19 Pandemic Udayakumar Navaneethan, Dennisdhilak Lourdusamy, Vanessa LehnerNoguera, Bo Shen
110 [GO] 2020―Jul―06 A Challenging Colectomy for Acute Severe Ulcerative Colitis Complicated by COVID-19 Mirko Di Ruscio, Angela Variola, Andrea Angheben, Silvia Resimini, Andrea Geccherle, Giacomo Ruffo, Giuliano Barugola
111 [GO] 2020―Jul―03 The Incidence and Outcomes of COVID-19 in IBD Patients: A Rapid Review and Meta-analysis Muhammad Aziz, Rawish Fatima, Hossein Haghbin, Wade Lee-Smith, Ali Nawras
112 [GO] 2020―Jul―03 Reply to the Letter to the Editor: The Incidence and Outcomes of COVID-19 in Patients With IBD: A Rapid Review and Meta-Analysis Juan F Burgueño, Maria T Abreu
113 [GO] 2020―Jul―03 Should We Be Screening for SARS-CoV-2 in IBD Patients Before Initiation of Biologic Therapy? Jana G Hashash, Suha Jabak, Fadi F Francis, Miguel Regueiro
114 [GO] 2020―Jul―03 Review of Societal Recommendations Regarding Management of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic Laurie B Grossberg, Randall S Pellish, Adam S Cheifetz, Joseph D Feuerstein
115 [GO] 2020―Jun―27 Managing an IBD Infusion Unit During the COVID-19 Pandemic: Service Modifications and the Patient Perspective Jennie N Clough, Katie L Hill, Alexa Duff, Esha Sharma, Shuvra Ray, Joel E Mawdsley, et al. (+3)
116 [GO] 2020―Jun―24 From the American Epicenter: Coronavirus Disease 2019 in Patients with Inflammatory Bowel Disease in the New York City Metropolitan Area Jordan E Axelrad, Lisa Malter, Simon Hong, Shannon Chang, Brian Bosworth, David Hudesman
117 [GO] 2020―Jun―24 Prolonged Duration of SARS-CoV-2 Viral Positivity in a Crohn’s Disease Patient Udayakumar Navaneethan, Vanessa LehnerNoguera
118 [GO] 2020―Jun―12 Inflammatory Bowel Disease and COVID-19-“Preventive” Sick Certificates as a Frequent Coping Strategy in the Face of the Pandemic Franziska Schlabitz, Niels Teich, Patrick Michl, Jens Walldorf
119 [GO] 2020―Jun―04 Management of COVID-19 Pandemic in Spanish Inflammatory Bowel Disease Units: Results From a National Survey Eduardo Martin Arranz, Cristina Suarez Ferrer, Laura García Ramírez, Jose Luis Rueda García, María Sánchez-Azofra, Joaquín Poza Cordón, et al. (+4)
120 [GO] 2020―Jun―01 The Greek Response to COVID-19: A True Success Story from an IBD Perspective Giorgos Bamias, Styliani Lagou, Michalis Gizis, George Karampekos, Konstantinos G Kyriakoulis, Christos Pontas, Gerassimos J Mantzaris
121 [GO] 2020―Mai―25 IBD in the Times of COVID-19 Stefany Hernández Benabe, Amber H Langshaw
122 [GO] 2020―Mai―22 Clinical and Psychological Issues in Children with Inflammatory Bowel Disease During COVID-19 Pandemic Massimo Martinelli, Caterina Strisciuglio, Flora Fedele, Erasmo Miele, Annamaria Staiano
123 [GO] 2020―Mai―22 Temporal Correlation Between Neurological and Gastrointestinal Symptoms of SARS-CoV-2 Mehmet Bostancıklıoğlu
124 [GO] 2020―Mai―12 Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID-19 Infection: A Case Report and Review of the Literature Melissa H Rosen, Jordan Axelrad, David Hudesman, David T Rubin, Shannon Chang
125 [GO] 2020―Mai―09 Inflammatory Bowel Diseases and Biological Treatment in SARS-CoV-2 Era. Why Not? Roberto Grassia, Sara Soro, Clara Benedetta Conti
126 [GO] 2020―Mai―08 Anti-TNF-α Agents in Inflammatory Bowel Disease and Course of COVID-19 Antonio Tursi, Lorenzo Maria Vetrone, Alfredo Papa
127 [GO] 2020―Apr―28 Case Report of a SARS-CoV-2 Infection in a Patient With Ulcerative Colitis on Tofacitinib Jeffrey Jacobs, Kindra Clark-Snustad, Scott Lee
128 [GO] 2020―Apr―25 Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD Juan F Burgueño, Adrian Reich, Hajar Hazime, Maria A Quintero, Fernandez Irina, Julia Fritsch, et al. (+11)
129 [GO] 2020―Apr―21 Challenges in the Care of IBD Patients During the CoViD-19 Pandemic: Report From a “Red Zone” Area in Northern Italy Vincenzo Occhipinti, Luca Pastorelli
 [1] 

129 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.007 sec